Solventum to Participate in Upcoming Investor Conferences
Rhea-AI Summary
Solventum (NYSE: SOLV), a healthcare company, has announced its participation in two upcoming investor conferences. The first is the 2024 Wells Fargo Healthcare Conference in Everett, MA on September 4, 2024, at 11:00 a.m. ET. The second is the Morgan Stanley 22nd Annual Global Healthcare Conference in New York, NY on September 5, 2024, at 11:30 a.m. ET.
These conferences provide Solventum with opportunities to present to investors and analysts. The company will offer live and archived audio webcasts of their presentations on their investor relations website at investors.solventum.com, allowing wider access to their updates and strategies.
Positive
- None.
Negative
- None.
News Market Reaction 1 Alert
On the day this news was published, SOLV declined 0.83%, reflecting a mild negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
- 2024 Wells Fargo Healthcare Conference in
Everett, MA on Wednesday, September 4, 2024 at 11:00 a.m. ET. - Morgan Stanley 22nd Annual Global Healthcare Conference in
New York, NY on Thursday, September 5, 2024 at 11:30 a.m. ET.
Live and archived audio webcasts will be available on the company's website at investors.solventum.com.
About Solventum
At Solventum, we enable better, smarter, safer healthcare to improve lives. As a new company with a long legacy of creating breakthrough solutions for our customers' toughest challenges, we pioneer game-changing innovations at the intersection of health, material and data science that change patients' lives for the better — while empowering healthcare professionals to perform at their best. See how at Solventum.com.
View original content to download multimedia:https://www.prnewswire.com/news-releases/solventum-to-participate-in-upcoming-investor-conferences-302232297.html
SOURCE Solventum